NIH participates in the
Global Alliance for Chronic Diseases (GACD), a collection of publicly funded research agencies that supports innovative research collaborations to address the prevention and treatment of chronic diseases in vulnerable populations.
View and filter
Scale Up |
Mental Health |
Lung Disease |
Type 2 Diabetes |
Scaling-up Evidence-based Interventions
GACD is focusing on
scaling-up evidence-based interventions at the population level for the prevention or management of hypertension or diabetes.
GACD Mental Health Research
GACD funding agencies are accepting implementation research proposals on
child, adolescent and adult age onset mental disorders including, but not limited to, dementia, depression, schizophrenia, bipolar disorders, alcohol- and drug-use disorders, etc., in low- and middle-income countries and/or in vulnerable populations in high-income countries.
GACD Lung Disease Research
GACD member organizations will accept implementation research proposals to address
lung diseases related to environmental exposures, including indoor and outdoor air pollution and tobacco. Eligibility and application deadlines will vary by organization, and details will be released over time by each organization.
GACD Type 2 Diabetes Research
GACD member organizations, including NIH, recently solicited applications on
type 2 diabetes with a focus on improving the science around implementation of existing interventions. NIH applications were accepted through the trans-NIH Initiative on Dissemination and Implementation Science for February 2014 application due dates.
GACD Hypertension Research
GACD members chose
hypertension as their first joint funding initiative. Grants were announced in June 2012.
Updated May 16, 2019